bpc-157 human clinical trial musculoskeletal pain Regeneration or Risk? A Narrative Review of for Healing BPC-157 Peptide Therapy | Regenerative
Description
doi:10.1186/1472-6882-12-97

Safety Profile of BPC-157 BPC-157 is generally well-tolerated at 500 mcg/day, with rare side effects like mild nausea or headaches ( 50 mg/day) may cause digestive upset

But the thigh is the best option for people who experience significant nausea, prefer clear visibility of the injection, or have limited subcutaneous fat in the abdominal area

I see four basic options, labeled below